Scarica l'app Stockscreener
0.175
2.34%
0.004
Pre-mercato:
.20
0.025
+14.29%
Liminatus Pharma Inc Borsa (LIMN) Ultime notizie
Growth Value: Is Liminatus Pharma Inc forming a breakout pattern2026 Patterns & Entry Point Strategy Guides - baoquankhu1.vn
Retail Trends: Whats the fair value of Liminatus Pharma Inc Equity Warrant stock2026 Intraday Action & Weekly Sector Rotation Insights - baoquankhu1.vn
Liminatus Pharma 2025 Annual Report: Pre-Clinical Cancer Therapy Pipeline, Strategy, and Risk Overview - Minichart
Liminatus Pharma 2025 10-K — $0 Revenue, Net Loss $10.21M - TradingView
Liminatus Pharma (NASDAQ: LIMN) faces cash strain, dilution and Nasdaq listing risks - stocktitan.net
Insider Trends: Is Liminatus Pharma Inc stock a smart retirement pick2026 PreEarnings & Weekly Return Optimization Plans - baoquankhu1.vn
FOMO Trade: Is Liminatus Pharma Inc a good ESG investment2026 Momentum & Capital Efficient Trading Techniques - baoquankhu1.vn
Institution Moves: Is Liminatus Pharma Inc stock a top performer YTD2026 Buyback Activity & Stepwise Trade Execution Plans - baoquankhu1.vn
Jobs Data: What are the future prospects of Liminatus Pharma Inc Equity WarrantTrade Analysis Report & AI Driven Price Predictions - baoquankhu1.vn
Fundamentals Check: Is Liminatus Pharma Inc Equity Warrant subject to activist investor interest2026 Breakouts & Daily Profit Focused Stock Screening - baoquankhu1.vn
Moving Averages: What are Liminatus Pharma Incs recent SEC filings showingJobs Report & Verified Momentum Stock Alerts - baoquankhu1.vn
LIMN Stock Price, Quote & Chart | LIMINATUS PHARMA INC-CL A (NASDAQ:LIMN) - ChartMill
Weekly Earnings: Is Liminatus Pharma Inc Equity Warrant stock undervalued right nowMarket Activity Summary & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
Aug Patterns: Can BPMC maintain its current growth rate2026 Fundamental Recap & Accurate Technical Buy Alerts - baoquankhu1.vn
Liminatus eyes clinic with CD47-blockade antibody IBA-101 - BioWorld MedTech
Liminatus Pharma to initiate Phase 1 clinical trial for IBA101 antibody - TipRanks
Liminatus Pharma’s IBA101 May Represent the CD47 Innovation Addressing Anemia and Thrombocytopenia in Advanced Immuno-Oncology - Bitget
Liminatus Pharma announces planned phase 1 clinical trial of IBA101, a next-generation CD47 blocking antibody - marketscreener.com
Liminatus Pharma Announces Planned Phase 1 Clinical Trial of IBA101, a Next-Generation CD47 Blocking Antibody - The Manila Times
Liminatus Pharma Announces Planned Phase 1 Clinical Trial Of Iba101, A Next-Generation Cd47 Blocking Antibody - TradingView
New 'don't-eat-me' cancer antibody to be tested in Liminatus lung trial - Stock Titan
Aug Movers: Is Liminatus Pharma Inc stock a top performer YTD2026 Trends & Smart Money Movement Tracker - baoquankhu1.vn
Reviewing Athira Pharma (NASDAQ:LONA) and Liminatus Pharma (NASDAQ:LIMN) - Defense World
Insider Trends: Is Liminatus Pharma Inc Equity Warrant subject to activist investor interestWeekly Trade Recap & Reliable Volume Spike Alerts - baoquankhu1.vn
Liminatus Pharma Stock Surges to Record High After Regaining Nasdaq Compliance - MSN
Aug Mood: Is Liminatus Pharma Inc a strong growth stock2026 Breakouts & Fast Moving Stock Trade Plans - baoquankhu1.vn
How Liminatus Pharma Inc. stock responds to policy changesQuarterly Earnings Report & Expert Curated Trade Setup Alerts - Naître et grandir
Winners Losers: Is Liminatus Pharma Inc Equity Warrant subject to activist investor interestJuly 2025 Drop Watch & Weekly Momentum Picks - baoquankhu1.vn
Liminatus Pharma Lowers Quorum Requirement in Bylaw Amendment - TipRanks
Aug Update: Is Liminatus Pharma Inc stock a smart retirement pickJuly 2025 Retail & Reliable Entry Point Trade Alerts - baoquankhu1.vn
LIMN Earnings History & Surprises | EPS & Revenue Results | LIMINATUS PHARMA INC-CL A (NASDAQ:LIMN) - ChartMill
LIMN Should I Buy - Intellectia AI
Basic earnings per share (basic EPS) of Liminatus Pharma, Inc. – NASDAQ:LIMNW - TradingView
Liminatus Pharma Inc. (NASDAQ:LIMN) Short Interest Up 4,357.6% in February - Defense World
LIMN PE Ratio & Valuation, Is LIMN Overvalued - Intellectia AI
Free float of Liminatus Pharma, Inc. – NASDAQ:LIMNW - TradingView
Critical Analysis: Liminatus Pharma (NASDAQ:LIMN) and Athira Pharma (NASDAQ:LONA) - Defense World
Net income of Liminatus Pharma, Inc. – NASDAQ:LIMNW - TradingView
Liminatus Pharma, Inc. Dividends – NASDAQ:LIMNW - TradingView
Liminatus Pharma, Inc. Signs MOU with Capital Trust Group for USD 30 Million Equity Investment via an earn-out mechanism and Future Strategic Cooperation - The Ames Tribune
Aug EndMonth: What are Liminatus Pharma Incs recent SEC filings showingQuarterly Profit Report & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Earnings Risk: What are Liminatus Pharma Incs recent SEC filings showing2025 Top Gainers & Free Growth Oriented Trading Recommendations - baoquankhu1.vn
Can Liminatus Pharma Inc. Equity Warrant stock deliver strong Q4 earnings2025 Historical Comparison & AI Forecast Swing Trade Picks - mfd.ru
Trend Recap: What is QSIAWs valuation compared to sectorProfit Target & High Conviction Investment Ideas - baoquankhu1.vn
Liminatus Pharma (NASDAQ: LIMN) insiders report 2.07M shares, 4.99% stake - stocktitan.net
Liminatus Pharma Completes $4 Million Public Equity Offering - The Globe and Mail
Liminatus Pharma Prices $0.29 Equity Offering, Nets $3.46 Million Under Securities Purchase Pact - TradingView
Aug Highlights: Can Liminatus Pharma Inc Equity Warrant be recession proofJuly 2025 Short Interest & Verified Stock Trade Ideas - baoquankhu1.vn
Liminatus Pharma prices $4 million public offering at $0.29 per share - Investing.com India
Liminatus Pharma prices 13.8M shares at 29c in public offering - TipRanks
Gold Down 3%; Medtronic Earnings Top Views - Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Liminatus Pharma, Inc. Announces Pricing of $4.0 Million Public Offering - Bitget
BillionToOne to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026 - The Manila Times
Bond Watch: What dividend growth rate does Sun Communities Inc offerWeekly Market Report & Fast Exit and Entry Strategy Plans - baoquankhu1.vn
History Review: Is MasterBrand Inc benefiting from interest rate changesPortfolio Growth Summary & Accurate Intraday Trade Tips - baoquankhu1.vn
Is Liminatus Pharma Inc. Equity Warrant subject to activist investor interestTrade Volume Report & Long-Term Investment Growth Plans - mfd.ru
Published on: 2026-02-15 22:28:13 - mfd.ru
Can Liminatus Pharma Inc. Equity Warrant be recession proofTake Profit & Safe Capital Investment Plans - mfd.ru
Why Liminatus Pharma Inc. Equity Warrant stock is recommended by analysts2025 Market Overview & AI Driven Price Predictions - mfd.ru
Bond Watch: Can Xtant Medical Holdings Inc. (XMS) stock withstand sector downturnsJuly 2025 Volume & Long Hold Capital Preservation Tips - mfd.ru
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):